AG
CELG

Artal Group’s Celgene Corp CELG Stock Holding History

Artal Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100,000
Closed -$12M – 115
2016
Q4 		$11.6M Buy
+100,000
New +$11.1M 0.26% 33
2016
Q2 		– Sell
-360,000
Closed -$37.2M – 81
2016
Q1 		$36M Buy
360,000
+260,000
+260% +$26.8M 0.7% 10
2015
Q4 		$12M Buy
+100,000
New +$11.6M 0.22% 46

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Artal Group's CELG Position: Q1 2017 in Review

Artal Group sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 100,000 shares — an estimated $12M sold.

Artal Group first reported a position in CELG in Q4 2015 and held it in 3 quarters. The position peaked at $36M in Q1 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Artal Group reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
  • Artal Group sold 100,000 Celgene Corp shares in Q1 2017, an estimated $12M.
  • Artal Group first reported a position in Celgene Corp in Q4 2015 and held it in 3 quarters.
  • Artal Group's Celgene Corp position peaked at $36M in Q1 2016.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Artal Group's 13F filing for Q1 2017, filed 15 May 2017.